MUC2 and metastatic malignant neoplasm in the lymph nodes: The meta-analysis demonstrated that a low level of MUC2 expression was associated with lymph node metastasis in patients with CRC (RR, 1.41; 95% CI, 1.25–1.60; P < 0.00001; Figure 3(b)).